| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Hyperplasia | 65 | 2021 | 530 | 5.900 |
Why?
|
| Mass Screening | 101 | 2024 | 5423 | 5.060 |
Why?
|
| Prostate-Specific Antigen | 68 | 2020 | 2529 | 4.920 |
Why?
|
| Prostatic Neoplasms | 106 | 2020 | 11345 | 4.040 |
Why?
|
| Patient Participation | 41 | 2023 | 1439 | 3.610 |
Why?
|
| Decision Support Techniques | 41 | 2024 | 2001 | 3.320 |
Why?
|
| Decision Making | 56 | 2023 | 3925 | 3.020 |
Why?
|
| Preventive Health Services | 29 | 2023 | 570 | 2.900 |
Why?
|
| Advisory Committees | 40 | 2024 | 788 | 2.490 |
Why?
|
| Early Detection of Cancer | 33 | 2024 | 3202 | 2.310 |
Why?
|
| Prostatectomy | 47 | 2021 | 1956 | 1.630 |
Why?
|
| Patient-Centered Care | 9 | 2021 | 1416 | 1.560 |
Why?
|
| Urination Disorders | 11 | 2011 | 240 | 1.550 |
Why?
|
| Physician-Patient Relations | 13 | 2020 | 3242 | 1.350 |
Why?
|
| Primary Health Care | 32 | 2024 | 4647 | 1.250 |
Why?
|
| Economics, Pharmaceutical | 3 | 2020 | 88 | 1.240 |
Why?
|
| Ireland | 18 | 2020 | 172 | 1.230 |
Why?
|
| Urology | 20 | 2021 | 423 | 1.140 |
Why?
|
| Evidence-Based Medicine | 10 | 2023 | 3696 | 1.070 |
Why?
|
| Patient Preference | 12 | 2023 | 922 | 1.060 |
Why?
|
| Watchful Waiting | 9 | 2017 | 510 | 1.020 |
Why?
|
| Phytotherapy | 6 | 2012 | 295 | 1.000 |
Why?
|
| Humans | 409 | 2024 | 760621 | 0.950 |
Why?
|
| Prostatitis | 7 | 2007 | 102 | 0.950 |
Why?
|
| Behavior Therapy | 10 | 2024 | 868 | 0.930 |
Why?
|
| Unnecessary Procedures | 4 | 2016 | 413 | 0.920 |
Why?
|
| Lipid Metabolism Disorders | 1 | 2023 | 20 | 0.900 |
Why?
|
| Technology Assessment, Biomedical | 6 | 2020 | 306 | 0.900 |
Why?
|
| Counseling | 10 | 2022 | 1548 | 0.890 |
Why?
|
| Male | 262 | 2023 | 359744 | 0.880 |
Why?
|
| Conflict of Interest | 3 | 2021 | 549 | 0.870 |
Why?
|
| Patient Education as Topic | 18 | 2020 | 2315 | 0.840 |
Why?
|
| Erectile Dysfunction | 7 | 2021 | 452 | 0.820 |
Why?
|
| Finasteride | 8 | 2011 | 90 | 0.810 |
Why?
|
| Models, Econometric | 3 | 2020 | 216 | 0.810 |
Why?
|
| Cystic Fibrosis | 2 | 2021 | 1274 | 0.790 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 5 | 2022 | 3334 | 0.750 |
Why?
|
| Cost-Benefit Analysis | 24 | 2020 | 5508 | 0.750 |
Why?
|
| Benzimidazoles | 3 | 2018 | 858 | 0.720 |
Why?
|
| Quality of Life | 32 | 2023 | 13308 | 0.720 |
Why?
|
| Aged | 170 | 2024 | 169152 | 0.700 |
Why?
|
| Electronic Prescribing | 1 | 2021 | 114 | 0.700 |
Why?
|
| United States | 95 | 2024 | 72461 | 0.700 |
Why?
|
| Osteoarthritis, Hip | 3 | 2021 | 406 | 0.690 |
Why?
|
| 5-alpha Reductase Inhibitors | 5 | 2011 | 117 | 0.680 |
Why?
|
| Pharmacy | 2 | 2020 | 92 | 0.680 |
Why?
|
| Group Practice | 1 | 2020 | 151 | 0.650 |
Why?
|
| Asymptomatic Diseases | 10 | 2024 | 587 | 0.640 |
Why?
|
| Middle Aged | 156 | 2024 | 220352 | 0.640 |
Why?
|
| Health Knowledge, Attitudes, Practice | 12 | 2021 | 3986 | 0.630 |
Why?
|
| Reimbursement Mechanisms | 6 | 2020 | 664 | 0.620 |
Why?
|
| Plant Extracts | 5 | 2013 | 496 | 0.610 |
Why?
|
| Androgen Antagonists | 6 | 2012 | 1442 | 0.600 |
Why?
|
| Quality-Adjusted Life Years | 11 | 2020 | 1724 | 0.590 |
Why?
|
| Cooperative Behavior | 4 | 2016 | 1500 | 0.590 |
Why?
|
| Adrenergic alpha-Antagonists | 10 | 2009 | 174 | 0.590 |
Why?
|
| Arthritis, Psoriatic | 2 | 2011 | 219 | 0.590 |
Why?
|
| Health Status | 14 | 2016 | 4081 | 0.580 |
Why?
|
| Urinary Incontinence | 6 | 2017 | 495 | 0.570 |
Why?
|
| Carotid Stenosis | 2 | 2021 | 878 | 0.560 |
Why?
|
| Practice Guidelines as Topic | 15 | 2022 | 7475 | 0.540 |
Why?
|
| Models, Economic | 6 | 2016 | 719 | 0.540 |
Why?
|
| Serenoa | 5 | 2013 | 11 | 0.540 |
Why?
|
| Randomized Controlled Trials as Topic | 19 | 2019 | 10344 | 0.530 |
Why?
|
| Urination | 3 | 2016 | 202 | 0.530 |
Why?
|
| Preventive Medicine | 3 | 2023 | 250 | 0.530 |
Why?
|
| Radiation Oncology | 4 | 2015 | 563 | 0.520 |
Why?
|
| Tennis | 1 | 2016 | 20 | 0.520 |
Why?
|
| Trust | 1 | 2020 | 532 | 0.510 |
Why?
|
| Risk Assessment | 46 | 2024 | 24123 | 0.510 |
Why?
|
| Robotics | 3 | 2012 | 874 | 0.510 |
Why?
|
| Physicians, Family | 6 | 2010 | 349 | 0.510 |
Why?
|
| Equipment and Supplies | 1 | 2018 | 275 | 0.500 |
Why?
|
| Dental Caries | 3 | 2023 | 420 | 0.490 |
Why?
|
| Drug Industry | 2 | 2020 | 789 | 0.480 |
Why?
|
| Occult Blood | 5 | 2022 | 197 | 0.480 |
Why?
|
| Transurethral Resection of Prostate | 5 | 2009 | 85 | 0.480 |
Why?
|
| Brachial Plexus Neuritis | 1 | 2014 | 20 | 0.470 |
Why?
|
| Aortic Aneurysm, Abdominal | 5 | 2022 | 1223 | 0.460 |
Why?
|
| Pathology Department, Hospital | 1 | 2013 | 10 | 0.460 |
Why?
|
| Adult | 113 | 2024 | 219994 | 0.460 |
Why?
|
| Patients | 8 | 2020 | 906 | 0.450 |
Why?
|
| Osteoarthritis, Knee | 3 | 2021 | 1234 | 0.450 |
Why?
|
| Cardiovascular Diseases | 15 | 2023 | 15757 | 0.450 |
Why?
|
| Predatory Behavior | 2 | 2004 | 25 | 0.450 |
Why?
|
| Biopsy | 8 | 2018 | 6771 | 0.440 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2021 | 3164 | 0.440 |
Why?
|
| Malpractice | 3 | 2021 | 556 | 0.440 |
Why?
|
| Health Facility Merger | 1 | 2013 | 47 | 0.440 |
Why?
|
| Urodynamics | 7 | 2016 | 346 | 0.430 |
Why?
|
| Health Status Indicators | 8 | 2015 | 968 | 0.430 |
Why?
|
| Death Certificates | 1 | 2013 | 167 | 0.420 |
Why?
|
| Anticoagulants | 5 | 2022 | 4897 | 0.410 |
Why?
|
| Prostate | 12 | 2021 | 1793 | 0.410 |
Why?
|
| Colorectal Neoplasms | 7 | 2022 | 6853 | 0.400 |
Why?
|
| Orchiectomy | 2 | 2006 | 470 | 0.400 |
Why?
|
| Tendon Injuries | 1 | 2016 | 327 | 0.400 |
Why?
|
| Tetrazoles | 1 | 2018 | 905 | 0.400 |
Why?
|
| Plant Preparations | 1 | 2012 | 94 | 0.400 |
Why?
|
| Smoking Cessation | 4 | 2021 | 2064 | 0.400 |
Why?
|
| Female | 118 | 2024 | 391270 | 0.380 |
Why?
|
| Severity of Illness Index | 12 | 2021 | 15840 | 0.380 |
Why?
|
| Pregnancy Complications, Infectious | 5 | 2023 | 2125 | 0.380 |
Why?
|
| Azasteroids | 1 | 2011 | 37 | 0.370 |
Why?
|
| Urinary Incontinence, Urge | 1 | 2011 | 50 | 0.370 |
Why?
|
| Minerals | 2 | 2022 | 283 | 0.370 |
Why?
|
| Interdisciplinary Communication | 1 | 2016 | 934 | 0.370 |
Why?
|
| Primary Prevention | 7 | 2022 | 1207 | 0.370 |
Why?
|
| Pelvic Pain | 3 | 2007 | 298 | 0.370 |
Why?
|
| Disclosure | 3 | 2021 | 738 | 0.360 |
Why?
|
| Videotape Recording | 4 | 2015 | 337 | 0.350 |
Why?
|
| SEER Program | 7 | 2017 | 1530 | 0.350 |
Why?
|
| Physical Examination | 7 | 2023 | 1244 | 0.350 |
Why?
|
| Mentally Ill Persons | 1 | 2011 | 127 | 0.350 |
Why?
|
| Dietary Supplements | 6 | 2023 | 3392 | 0.350 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2010 | 83 | 0.350 |
Why?
|
| Health Behavior | 6 | 2021 | 2622 | 0.340 |
Why?
|
| Warfarin | 3 | 2009 | 1518 | 0.340 |
Why?
|
| Aged, 80 and over | 49 | 2022 | 58995 | 0.330 |
Why?
|
| Health Services Research | 7 | 2023 | 1810 | 0.330 |
Why?
|
| Comparative Effectiveness Research | 2 | 2016 | 718 | 0.330 |
Why?
|
| Vision Screening | 2 | 2022 | 69 | 0.330 |
Why?
|
| Ultrasonography | 7 | 2021 | 5961 | 0.330 |
Why?
|
| Incidental Findings | 1 | 2014 | 698 | 0.330 |
Why?
|
| Depression | 7 | 2023 | 8044 | 0.320 |
Why?
|
| Hypoglycemic Agents | 4 | 2018 | 3150 | 0.320 |
Why?
|
| Cavernous Sinus | 1 | 2010 | 123 | 0.320 |
Why?
|
| Hepatitis B Vaccines | 2 | 2020 | 186 | 0.320 |
Why?
|
| Hepatitis B | 2 | 2019 | 701 | 0.310 |
Why?
|
| Antidepressive Agents | 3 | 2020 | 2890 | 0.310 |
Why?
|
| Vitamins | 3 | 2022 | 1634 | 0.310 |
Why?
|
| Publishing | 1 | 2016 | 836 | 0.310 |
Why?
|
| Progestins | 2 | 2022 | 302 | 0.310 |
Why?
|
| Pharmaceutical Preparations | 1 | 2016 | 1091 | 0.310 |
Why?
|
| Dyslipidemias | 4 | 2023 | 895 | 0.300 |
Why?
|
| Models, Psychological | 2 | 2012 | 827 | 0.300 |
Why?
|
| Quality Indicators, Health Care | 2 | 2016 | 1824 | 0.300 |
Why?
|
| Syphilis | 2 | 2022 | 241 | 0.300 |
Why?
|
| Life Expectancy | 8 | 2015 | 1248 | 0.300 |
Why?
|
| Ankle Brachial Index | 2 | 2018 | 163 | 0.290 |
Why?
|
| Adolescent | 39 | 2024 | 87810 | 0.290 |
Why?
|
| Human papillomavirus 18 | 1 | 2008 | 125 | 0.290 |
Why?
|
| Diabetes Mellitus, Type 2 | 9 | 2022 | 12293 | 0.290 |
Why?
|
| Age Factors | 23 | 2024 | 18416 | 0.290 |
Why?
|
| Cystitis, Interstitial | 1 | 2007 | 66 | 0.290 |
Why?
|
| Digital Rectal Examination | 4 | 2017 | 40 | 0.280 |
Why?
|
| Exercise Therapy | 4 | 2024 | 919 | 0.280 |
Why?
|
| Risk Factors | 46 | 2022 | 74359 | 0.280 |
Why?
|
| Physicians | 7 | 2018 | 4591 | 0.280 |
Why?
|
| Acetone | 2 | 2017 | 44 | 0.280 |
Why?
|
| Prostatic Diseases | 3 | 1996 | 57 | 0.280 |
Why?
|
| Gout | 3 | 2021 | 620 | 0.280 |
Why?
|
| Psychometrics | 6 | 2020 | 3051 | 0.280 |
Why?
|
| Anti-Retroviral Agents | 3 | 2023 | 1779 | 0.280 |
Why?
|
| Professional-Patient Relations | 1 | 2012 | 726 | 0.280 |
Why?
|
| Quality of Health Care | 6 | 2016 | 4360 | 0.280 |
Why?
|
| Hepatitis B virus | 2 | 2020 | 522 | 0.270 |
Why?
|
| Human papillomavirus 16 | 1 | 2008 | 265 | 0.270 |
Why?
|
| Arthroplasty, Replacement, Hip | 3 | 2020 | 1406 | 0.270 |
Why?
|
| Mass Vaccination | 1 | 2007 | 109 | 0.270 |
Why?
|
| Opioid-Related Disorders | 1 | 2021 | 2138 | 0.270 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2010 | 448 | 0.270 |
Why?
|
| Reproducibility of Results | 15 | 2023 | 20080 | 0.270 |
Why?
|
| Patient Satisfaction | 7 | 2023 | 3448 | 0.270 |
Why?
|
| Enzyme Inhibitors | 7 | 2008 | 3726 | 0.260 |
Why?
|
| Antineoplastic Agents, Hormonal | 2 | 2006 | 1529 | 0.260 |
Why?
|
| Prediabetic State | 2 | 2022 | 550 | 0.260 |
Why?
|
| Independent Living | 4 | 2024 | 570 | 0.260 |
Why?
|
| Health Care Costs | 9 | 2015 | 3258 | 0.260 |
Why?
|
| Psychotherapy | 4 | 2024 | 1640 | 0.260 |
Why?
|
| Immunization Programs | 1 | 2008 | 268 | 0.250 |
Why?
|
| Amphetamine | 2 | 2017 | 224 | 0.250 |
Why?
|
| Drug Contamination | 2 | 2017 | 152 | 0.250 |
Why?
|
| Sex | 2 | 2021 | 52 | 0.250 |
Why?
|
| Melanoma | 2 | 2023 | 5697 | 0.250 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2011 | 3763 | 0.240 |
Why?
|
| Designer Drugs | 2 | 2015 | 21 | 0.240 |
Why?
|
| Mammography | 5 | 2024 | 2427 | 0.240 |
Why?
|
| Water Pollution | 1 | 2004 | 33 | 0.240 |
Why?
|
| Public Health | 2 | 2023 | 2653 | 0.240 |
Why?
|
| Substance Abuse Detection | 2 | 2020 | 301 | 0.240 |
Why?
|
| Managed Care Programs | 2 | 2009 | 939 | 0.240 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2008 | 384 | 0.240 |
Why?
|
| Hormone Replacement Therapy | 2 | 2022 | 755 | 0.240 |
Why?
|
| False Positive Reactions | 7 | 2021 | 956 | 0.240 |
Why?
|
| Invertebrates | 1 | 2004 | 54 | 0.240 |
Why?
|
| Sensitivity and Specificity | 13 | 2021 | 14660 | 0.230 |
Why?
|
| Pneumococcal Vaccines | 1 | 2008 | 397 | 0.230 |
Why?
|
| Organizational Policy | 2 | 2021 | 429 | 0.230 |
Why?
|
| Medicare | 11 | 2012 | 6786 | 0.230 |
Why?
|
| Electronic Health Records | 1 | 2021 | 4775 | 0.230 |
Why?
|
| Cross-Sectional Studies | 14 | 2023 | 25942 | 0.230 |
Why?
|
| Water Microbiology | 1 | 2004 | 113 | 0.230 |
Why?
|
| Biopsy, Needle | 4 | 2007 | 1630 | 0.220 |
Why?
|
| Internal Medicine | 5 | 2009 | 1048 | 0.220 |
Why?
|
| Smoking | 3 | 2021 | 9073 | 0.220 |
Why?
|
| Pharyngitis | 1 | 2005 | 220 | 0.220 |
Why?
|
| Estrogens | 2 | 2022 | 1520 | 0.220 |
Why?
|
| Accidental Falls | 2 | 2024 | 1056 | 0.220 |
Why?
|
| Pneumococcal Infections | 1 | 2008 | 503 | 0.220 |
Why?
|
| Endovascular Procedures | 3 | 2022 | 2165 | 0.220 |
Why?
|
| Laparoscopy | 3 | 2012 | 2147 | 0.220 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2021 | 2282 | 0.210 |
Why?
|
| Influenza Vaccines | 1 | 2010 | 766 | 0.210 |
Why?
|
| Ambulatory Care | 3 | 2012 | 2781 | 0.210 |
Why?
|
| Folic Acid Deficiency | 1 | 2023 | 117 | 0.210 |
Why?
|
| Neoplasms | 9 | 2022 | 22072 | 0.210 |
Why?
|
| Child Abuse | 2 | 2024 | 1067 | 0.210 |
Why?
|
| Attitude of Health Personnel | 8 | 2017 | 3865 | 0.210 |
Why?
|
| Aspirin | 4 | 2022 | 3364 | 0.200 |
Why?
|
| Asymptomatic Infections | 2 | 2020 | 131 | 0.200 |
Why?
|
| Language Development Disorders | 1 | 2024 | 192 | 0.200 |
Why?
|
| Daphnia | 1 | 2002 | 19 | 0.200 |
Why?
|
| GABA Agents | 1 | 2002 | 41 | 0.200 |
Why?
|
| Osteoporosis | 3 | 2018 | 1600 | 0.200 |
Why?
|
| Focus Groups | 1 | 2008 | 1378 | 0.200 |
Why?
|
| Choice Behavior | 5 | 2019 | 821 | 0.200 |
Why?
|
| Cariostatic Agents | 1 | 2021 | 31 | 0.200 |
Why?
|
| Family Practice | 3 | 2000 | 510 | 0.200 |
Why?
|
| Papillomavirus Vaccines | 1 | 2008 | 495 | 0.200 |
Why?
|
| Fluorides, Topical | 1 | 2021 | 32 | 0.200 |
Why?
|
| Brachytherapy | 6 | 2013 | 1238 | 0.200 |
Why?
|
| Fluorobenzenes | 1 | 2004 | 180 | 0.200 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2018 | 2003 | 0.200 |
Why?
|
| Prescription Drugs | 2 | 2020 | 630 | 0.200 |
Why?
|
| Exercise | 5 | 2024 | 5787 | 0.200 |
Why?
|
| Herpes Genitalis | 1 | 2023 | 142 | 0.200 |
Why?
|
| Cholinergic Agents | 1 | 2002 | 96 | 0.200 |
Why?
|
| Hyperthermia, Induced | 2 | 2002 | 417 | 0.200 |
Why?
|
| Treatment Outcome | 26 | 2022 | 65017 | 0.190 |
Why?
|
| Cesarean Section, Repeat | 1 | 2021 | 29 | 0.190 |
Why?
|
| Pyridines | 2 | 2012 | 2879 | 0.190 |
Why?
|
| Survival Analysis | 8 | 2020 | 10182 | 0.190 |
Why?
|
| Child | 25 | 2024 | 79806 | 0.190 |
Why?
|
| Research Design | 7 | 2009 | 6180 | 0.190 |
Why?
|
| Washington | 5 | 2008 | 312 | 0.190 |
Why?
|
| Herpesvirus 2, Human | 1 | 2023 | 191 | 0.190 |
Why?
|
| Pregnancy | 19 | 2023 | 29749 | 0.190 |
Why?
|
| Oral Health | 2 | 2023 | 486 | 0.190 |
Why?
|
| Referral and Consultation | 10 | 2024 | 3598 | 0.190 |
Why?
|
| Pituitary Neoplasms | 1 | 2010 | 1313 | 0.190 |
Why?
|
| Adaptation, Biological | 1 | 2002 | 147 | 0.190 |
Why?
|
| Neural Tube Defects | 1 | 2023 | 254 | 0.190 |
Why?
|
| Aminophenols | 1 | 2021 | 86 | 0.190 |
Why?
|
| Atrial Fibrillation | 3 | 2022 | 5209 | 0.190 |
Why?
|
| Practice Management, Medical | 2 | 2004 | 191 | 0.190 |
Why?
|
| Trial of Labor | 1 | 2021 | 81 | 0.190 |
Why?
|
| Medical History Taking | 4 | 1992 | 773 | 0.180 |
Why?
|
| Vaginal Birth after Cesarean | 1 | 2021 | 61 | 0.180 |
Why?
|
| Streptococcal Infections | 1 | 2005 | 617 | 0.180 |
Why?
|
| Serologic Tests | 1 | 2023 | 383 | 0.180 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2022 | 1446 | 0.180 |
Why?
|
| Physician Incentive Plans | 3 | 2011 | 165 | 0.180 |
Why?
|
| Lung Neoplasms | 3 | 2021 | 13262 | 0.180 |
Why?
|
| Chronic Disease | 8 | 2023 | 9287 | 0.180 |
Why?
|
| Pregnancy Complications | 4 | 2023 | 2942 | 0.180 |
Why?
|
| Ureter | 1 | 2003 | 375 | 0.180 |
Why?
|
| Latent Tuberculosis | 1 | 2023 | 224 | 0.180 |
Why?
|
| Dementia | 4 | 2023 | 2649 | 0.180 |
Why?
|
| Bone Density Conservation Agents | 3 | 2018 | 796 | 0.170 |
Why?
|
| Diagnostic Tests, Routine | 3 | 2002 | 786 | 0.170 |
Why?
|
| Emotions | 3 | 2020 | 2734 | 0.170 |
Why?
|
| Periodontal Diseases | 1 | 2023 | 452 | 0.170 |
Why?
|
| Pre-Eclampsia | 2 | 2021 | 1229 | 0.170 |
Why?
|
| Postmenopause | 4 | 2022 | 2509 | 0.170 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2020 | 301 | 0.170 |
Why?
|
| Ophthalmia Neonatorum | 1 | 2019 | 1 | 0.170 |
Why?
|
| Antiviral Agents | 2 | 2020 | 3061 | 0.170 |
Why?
|
| Forecasting | 3 | 2023 | 2932 | 0.170 |
Why?
|
| Venous Thromboembolism | 1 | 2012 | 1864 | 0.170 |
Why?
|
| Genes, BRCA2 | 2 | 2019 | 603 | 0.170 |
Why?
|
| Societies, Medical | 8 | 2021 | 3905 | 0.160 |
Why?
|
| Connecticut | 3 | 2008 | 365 | 0.160 |
Why?
|
| Teaching Rounds | 1 | 2023 | 275 | 0.160 |
Why?
|
| Hormones | 2 | 2022 | 867 | 0.160 |
Why?
|
| Influenza, Human | 1 | 2010 | 1528 | 0.160 |
Why?
|
| Depressive Disorder, Major | 3 | 2023 | 4744 | 0.160 |
Why?
|
| Personality | 1 | 2022 | 552 | 0.160 |
Why?
|
| Bacteriuria | 1 | 2019 | 103 | 0.160 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2019 | 132 | 0.160 |
Why?
|
| Erythromycin | 1 | 2019 | 117 | 0.160 |
Why?
|
| Program Evaluation | 5 | 2014 | 2493 | 0.160 |
Why?
|
| Genes, BRCA1 | 2 | 2019 | 765 | 0.160 |
Why?
|
| Spinal Stenosis | 2 | 2020 | 262 | 0.160 |
Why?
|
| Pharmacopoeias as Topic | 1 | 2018 | 16 | 0.160 |
Why?
|
| Elder Abuse | 1 | 2018 | 36 | 0.160 |
Why?
|
| Communication | 5 | 2022 | 3849 | 0.160 |
Why?
|
| Male Urogenital Diseases | 1 | 1998 | 48 | 0.160 |
Why?
|
| Vaginosis, Bacterial | 1 | 2020 | 142 | 0.160 |
Why?
|
| Cohort Studies | 20 | 2021 | 41335 | 0.160 |
Why?
|
| Sexually Transmitted Diseases | 2 | 2022 | 628 | 0.150 |
Why?
|
| Markov Chains | 5 | 2013 | 968 | 0.150 |
Why?
|
| Follow-Up Studies | 24 | 2017 | 39261 | 0.150 |
Why?
|
| Risk | 8 | 2021 | 9631 | 0.150 |
Why?
|
| Multicenter Studies as Topic | 4 | 2019 | 1722 | 0.150 |
Why?
|
| Personal Satisfaction | 1 | 2022 | 643 | 0.150 |
Why?
|
| Hyperuricemia | 1 | 2021 | 225 | 0.150 |
Why?
|
| Breast Neoplasms | 8 | 2024 | 21025 | 0.150 |
Why?
|
| Chlamydia Infections | 1 | 2021 | 362 | 0.150 |
Why?
|
| Internet | 5 | 2021 | 3078 | 0.150 |
Why?
|
| Central Nervous System Stimulants | 2 | 2017 | 1174 | 0.150 |
Why?
|
| Colonoscopy | 3 | 2022 | 1387 | 0.150 |
Why?
|
| Reminder Systems | 2 | 2012 | 387 | 0.150 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2020 | 446 | 0.150 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2023 | 518 | 0.150 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2023 | 559 | 0.150 |
Why?
|
| Early Diagnosis | 5 | 2020 | 1180 | 0.150 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2023 | 3701 | 0.140 |
Why?
|
| Pregnant Women | 2 | 2019 | 563 | 0.140 |
Why?
|
| Advance Directives | 3 | 1994 | 248 | 0.140 |
Why?
|
| Young Adult | 18 | 2023 | 58741 | 0.140 |
Why?
|
| Acetonitriles | 1 | 2017 | 54 | 0.140 |
Why?
|
| Herpesvirus 1, Human | 1 | 2023 | 753 | 0.140 |
Why?
|
| Gonorrhea | 1 | 2021 | 343 | 0.140 |
Why?
|
| Educational Status | 4 | 2020 | 2515 | 0.140 |
Why?
|
| Sexual Behavior | 3 | 2021 | 2086 | 0.140 |
Why?
|
| Hypertension | 6 | 2022 | 8594 | 0.140 |
Why?
|
| Cardiopulmonary Resuscitation | 3 | 2015 | 1004 | 0.140 |
Why?
|
| Gynecological Examination | 1 | 2017 | 30 | 0.140 |
Why?
|
| Sunburn | 1 | 2018 | 156 | 0.140 |
Why?
|
| Electrocardiography | 3 | 2022 | 6414 | 0.140 |
Why?
|
| Neoplasm Staging | 8 | 2017 | 11152 | 0.140 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2015 | 9276 | 0.140 |
Why?
|
| Low Back Pain | 2 | 2017 | 979 | 0.140 |
Why?
|
| Prospective Studies | 20 | 2019 | 54303 | 0.140 |
Why?
|
| Osteoporotic Fractures | 2 | 2018 | 409 | 0.140 |
Why?
|
| Folic Acid | 1 | 2023 | 1309 | 0.140 |
Why?
|
| Probability | 6 | 2015 | 2475 | 0.140 |
Why?
|
| Point-of-Care Systems | 1 | 2005 | 1204 | 0.140 |
Why?
|
| Papillomavirus Infections | 1 | 2008 | 1607 | 0.140 |
Why?
|
| Lead Poisoning | 1 | 2019 | 321 | 0.130 |
Why?
|
| Hepatitis B, Chronic | 1 | 2020 | 403 | 0.130 |
Why?
|
| Carotid Arteries | 1 | 2021 | 951 | 0.130 |
Why?
|
| Logistic Models | 8 | 2016 | 13314 | 0.130 |
Why?
|
| Stents | 2 | 2012 | 3314 | 0.130 |
Why?
|
| Alcohol-Related Disorders | 1 | 2018 | 235 | 0.130 |
Why?
|
| Health Surveys | 7 | 2012 | 4063 | 0.130 |
Why?
|
| Data Collection | 7 | 2009 | 3315 | 0.130 |
Why?
|
| Drug Costs | 3 | 2020 | 1185 | 0.130 |
Why?
|
| Gender Identity | 1 | 2021 | 698 | 0.130 |
Why?
|
| Vaccination | 1 | 2008 | 3361 | 0.130 |
Why?
|
| Ejaculation | 1 | 1995 | 59 | 0.130 |
Why?
|
| Dystonia | 1 | 1999 | 364 | 0.130 |
Why?
|
| Genital Diseases, Female | 1 | 2017 | 191 | 0.130 |
Why?
|
| Natriuretic Peptide, Brain | 2 | 2015 | 1717 | 0.130 |
Why?
|
| Lipids | 2 | 2023 | 3336 | 0.130 |
Why?
|
| Penile Erection | 1 | 1995 | 100 | 0.130 |
Why?
|
| Incidence | 7 | 2015 | 21392 | 0.130 |
Why?
|
| Heparin | 1 | 2003 | 1652 | 0.130 |
Why?
|
| Physical Therapy Modalities | 2 | 2017 | 536 | 0.130 |
Why?
|
| Aromatase Inhibitors | 1 | 2019 | 511 | 0.130 |
Why?
|
| Vaginal Smears | 1 | 2018 | 495 | 0.130 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2022 | 734 | 0.130 |
Why?
|
| Genetic Counseling | 1 | 2019 | 624 | 0.130 |
Why?
|
| Fractures, Bone | 2 | 2018 | 2041 | 0.130 |
Why?
|
| Narcotic Antagonists | 1 | 2020 | 583 | 0.120 |
Why?
|
| Administration, Oral | 3 | 2019 | 4035 | 0.120 |
Why?
|
| Libido | 1 | 1995 | 119 | 0.120 |
Why?
|
| Combined Modality Therapy | 8 | 2021 | 8552 | 0.120 |
Why?
|
| Amblyopia | 1 | 2017 | 150 | 0.120 |
Why?
|
| Prevalence | 13 | 2022 | 15687 | 0.120 |
Why?
|
| Indenes | 1 | 2016 | 58 | 0.120 |
Why?
|
| Metformin | 3 | 2017 | 912 | 0.120 |
Why?
|
| Specialization | 3 | 2013 | 778 | 0.120 |
Why?
|
| Medication Errors | 1 | 2021 | 784 | 0.120 |
Why?
|
| Coitus | 1 | 1995 | 131 | 0.120 |
Why?
|
| Health Care Surveys | 3 | 2013 | 2435 | 0.120 |
Why?
|
| Dimethoxyphenylethylamine | 1 | 2014 | 3 | 0.120 |
Why?
|
| Tobacco Use Disorder | 1 | 2021 | 700 | 0.120 |
Why?
|
| Vulnerable Populations | 2 | 2018 | 696 | 0.120 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 4 | 2017 | 352 | 0.120 |
Why?
|
| Tamoxifen | 1 | 2019 | 963 | 0.120 |
Why?
|
| Vision Disorders | 1 | 2022 | 1084 | 0.120 |
Why?
|
| Documentation | 1 | 2021 | 893 | 0.120 |
Why?
|
| Time Factors | 12 | 2017 | 40165 | 0.120 |
Why?
|
| Medical Informatics Applications | 2 | 2008 | 178 | 0.120 |
Why?
|
| Ambulatory Care Information Systems | 2 | 2005 | 88 | 0.120 |
Why?
|
| Confidence Intervals | 6 | 2010 | 2932 | 0.120 |
Why?
|
| Diverticulitis | 1 | 1997 | 182 | 0.120 |
Why?
|
| Thigh | 1 | 2016 | 240 | 0.120 |
Why?
|
| Acetophenones | 1 | 2014 | 53 | 0.120 |
Why?
|
| Certification | 1 | 2018 | 421 | 0.120 |
Why?
|
| Anxiety Disorders | 2 | 2023 | 2714 | 0.120 |
Why?
|
| Interviews as Topic | 4 | 2011 | 2659 | 0.120 |
Why?
|
| Terminal Care | 3 | 2012 | 1758 | 0.120 |
Why?
|
| Stroke | 6 | 2022 | 9962 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2012 | 10827 | 0.120 |
Why?
|
| Insurance Pools | 1 | 2013 | 13 | 0.120 |
Why?
|
| Depression, Postpartum | 1 | 2019 | 345 | 0.120 |
Why?
|
| Insurance, Health, Reimbursement | 2 | 2009 | 385 | 0.110 |
Why?
|
| Sulfonamides | 1 | 2004 | 1977 | 0.110 |
Why?
|
| Disability Evaluation | 2 | 2013 | 1826 | 0.110 |
Why?
|
| Utilization Review | 1 | 2015 | 383 | 0.110 |
Why?
|
| Retrospective Studies | 16 | 2022 | 80372 | 0.110 |
Why?
|
| Urinary Retention | 2 | 2008 | 106 | 0.110 |
Why?
|
| Substance-Related Disorders | 2 | 2020 | 4371 | 0.110 |
Why?
|
| Disease Progression | 8 | 2021 | 13502 | 0.110 |
Why?
|
| Insurance Claim Review | 1 | 2018 | 738 | 0.110 |
Why?
|
| Health Education | 1 | 2020 | 1049 | 0.110 |
Why?
|
| Costs and Cost Analysis | 2 | 2016 | 1677 | 0.110 |
Why?
|
| Models, Statistical | 5 | 2013 | 5075 | 0.110 |
Why?
|
| Phytoplankton | 1 | 2013 | 4 | 0.110 |
Why?
|
| Health Policy | 5 | 2019 | 2677 | 0.110 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2017 | 409 | 0.110 |
Why?
|
| Immunoassay | 3 | 2019 | 746 | 0.110 |
Why?
|
| Lead | 1 | 2019 | 880 | 0.110 |
Why?
|
| Medical Oncology | 3 | 2010 | 2313 | 0.110 |
Why?
|
| Methamphetamine | 1 | 2015 | 162 | 0.110 |
Why?
|
| Massachusetts | 7 | 2016 | 8803 | 0.110 |
Why?
|
| Sampling Studies | 2 | 2013 | 613 | 0.110 |
Why?
|
| Models, Theoretical | 4 | 2014 | 3562 | 0.110 |
Why?
|
| Hepacivirus | 1 | 2020 | 1334 | 0.100 |
Why?
|
| Child, Preschool | 10 | 2024 | 42063 | 0.100 |
Why?
|
| ROC Curve | 3 | 2016 | 3568 | 0.100 |
Why?
|
| Radiotherapy | 5 | 2017 | 1504 | 0.100 |
Why?
|
| Case Management | 2 | 2011 | 272 | 0.100 |
Why?
|
| C-Reactive Protein | 2 | 2018 | 3839 | 0.100 |
Why?
|
| Attitude to Health | 8 | 2006 | 2029 | 0.100 |
Why?
|
| Community Health Planning | 1 | 2013 | 166 | 0.100 |
Why?
|
| Papillomaviridae | 1 | 2018 | 1117 | 0.100 |
Why?
|
| Coronary Disease | 2 | 2008 | 5990 | 0.100 |
Why?
|
| Suicide | 1 | 2023 | 1599 | 0.100 |
Why?
|
| Advance Care Planning | 2 | 2009 | 697 | 0.100 |
Why?
|
| Drug Prescriptions | 1 | 2021 | 1673 | 0.100 |
Why?
|
| Ovarian Neoplasms | 2 | 2019 | 4878 | 0.100 |
Why?
|
| Hepatitis C, Chronic | 1 | 2020 | 1031 | 0.100 |
Why?
|
| Survival Rate | 6 | 2010 | 12808 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 5 | 2020 | 7408 | 0.100 |
Why?
|
| Pyrimidines | 1 | 2004 | 3016 | 0.100 |
Why?
|
| Diabetes, Gestational | 1 | 2021 | 1242 | 0.100 |
Why?
|
| Reference Values | 2 | 2020 | 4925 | 0.100 |
Why?
|
| Premature Birth | 2 | 2021 | 1771 | 0.100 |
Why?
|
| Skin Neoplasms | 2 | 2023 | 5799 | 0.090 |
Why?
|
| Anecdotes as Topic | 1 | 2011 | 56 | 0.090 |
Why?
|
| Scoliosis | 1 | 2018 | 735 | 0.090 |
Why?
|
| Caregivers | 3 | 2023 | 2224 | 0.090 |
Why?
|
| Cause of Death | 3 | 2017 | 3725 | 0.090 |
Why?
|
| Patient Care Planning | 3 | 2010 | 908 | 0.090 |
Why?
|
| Research Subjects | 1 | 2013 | 249 | 0.090 |
Why?
|
| Audiovisual Aids | 1 | 2011 | 99 | 0.090 |
Why?
|
| Health Expenditures | 2 | 2020 | 2362 | 0.090 |
Why?
|
| Value of Life | 1 | 2011 | 98 | 0.090 |
Why?
|
| Information Systems | 1 | 2012 | 398 | 0.090 |
Why?
|
| Anxiety | 2 | 2023 | 4538 | 0.090 |
Why?
|
| Uncertainty | 4 | 2017 | 754 | 0.090 |
Why?
|
| Orthopedic Procedures | 1 | 2020 | 1263 | 0.090 |
Why?
|
| Antihypertensive Agents | 2 | 2017 | 2061 | 0.090 |
Why?
|
| Plant Bark | 1 | 2009 | 9 | 0.090 |
Why?
|
| Health Promotion | 1 | 2022 | 2206 | 0.090 |
Why?
|
| HIV Infections | 3 | 2023 | 17165 | 0.090 |
Why?
|
| Enoxaparin | 1 | 2012 | 397 | 0.090 |
Why?
|
| Blood Glucose | 3 | 2021 | 6381 | 0.090 |
Why?
|
| Vitamin D | 3 | 2018 | 3291 | 0.090 |
Why?
|
| Ultrasonography, Interventional | 1 | 2018 | 1502 | 0.090 |
Why?
|
| Patient Compliance | 3 | 2021 | 2688 | 0.080 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2022 | 1860 | 0.080 |
Why?
|
| Radiotherapy, Adjuvant | 3 | 2013 | 1791 | 0.080 |
Why?
|
| Psychotropic Drugs | 1 | 2015 | 883 | 0.080 |
Why?
|
| Odds Ratio | 6 | 2022 | 9716 | 0.080 |
Why?
|
| Morpholines | 1 | 2012 | 583 | 0.080 |
Why?
|
| Drug Therapy, Combination | 6 | 2019 | 6498 | 0.080 |
Why?
|
| Postoperative Complications | 7 | 2021 | 15697 | 0.080 |
Why?
|
| Alcohol Drinking | 2 | 2020 | 4013 | 0.080 |
Why?
|
| Guidelines as Topic | 2 | 2012 | 1392 | 0.080 |
Why?
|
| Cataract Extraction | 1 | 2013 | 465 | 0.080 |
Why?
|
| Blood Pressure Determination | 3 | 2023 | 640 | 0.080 |
Why?
|
| Celiac Disease | 1 | 2017 | 822 | 0.080 |
Why?
|
| Imidazoles | 1 | 2015 | 1180 | 0.080 |
Why?
|
| Prognosis | 11 | 2015 | 29658 | 0.080 |
Why?
|
| Thrombosis | 1 | 2003 | 3052 | 0.080 |
Why?
|
| Life Style | 2 | 2017 | 3896 | 0.080 |
Why?
|
| Patient Care Team | 3 | 2016 | 2511 | 0.080 |
Why?
|
| Chemoprevention | 1 | 2011 | 326 | 0.080 |
Why?
|
| Predictive Value of Tests | 6 | 2019 | 15289 | 0.080 |
Why?
|
| Case-Control Studies | 5 | 2016 | 22053 | 0.080 |
Why?
|
| Meningitis, Pneumococcal | 1 | 2008 | 43 | 0.080 |
Why?
|
| Congresses as Topic | 2 | 2017 | 805 | 0.080 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2019 | 1724 | 0.080 |
Why?
|
| Immunity, Herd | 1 | 2008 | 46 | 0.080 |
Why?
|
| Thiophenes | 1 | 2012 | 587 | 0.080 |
Why?
|
| Patient Discharge | 1 | 2021 | 3476 | 0.080 |
Why?
|
| Prazosin | 2 | 1998 | 95 | 0.070 |
Why?
|
| Infant | 7 | 2019 | 36060 | 0.070 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2018 | 1200 | 0.070 |
Why?
|
| Boston | 8 | 2010 | 9280 | 0.070 |
Why?
|
| Self Concept | 1 | 2014 | 1039 | 0.070 |
Why?
|
| Infectious Disease Transmission, Vertical | 3 | 2019 | 1348 | 0.070 |
Why?
|
| Arthroplasty, Replacement, Knee | 2 | 2020 | 1370 | 0.070 |
Why?
|
| San Francisco | 1 | 2007 | 162 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2023 | 4024 | 0.070 |
Why?
|
| Algorithms | 4 | 2020 | 13981 | 0.070 |
Why?
|
| Disease Management | 2 | 2012 | 2514 | 0.070 |
Why?
|
| Urinary Tract Infections | 2 | 2019 | 814 | 0.070 |
Why?
|
| Observer Variation | 1 | 2013 | 2601 | 0.070 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2015 | 2128 | 0.070 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 3224 | 0.070 |
Why?
|
| Carcinoma | 1 | 1998 | 2331 | 0.070 |
Why?
|
| Chromatography, Liquid | 3 | 2016 | 987 | 0.070 |
Why?
|
| Genotype | 1 | 2021 | 12960 | 0.070 |
Why?
|
| Immunization Schedule | 1 | 2008 | 224 | 0.070 |
Why?
|
| Intubation, Intratracheal | 1 | 2015 | 1328 | 0.070 |
Why?
|
| Orthopedics | 1 | 2016 | 892 | 0.070 |
Why?
|
| Medically Underserved Area | 1 | 2009 | 257 | 0.070 |
Why?
|
| Peripheral Arterial Disease | 1 | 2018 | 1306 | 0.070 |
Why?
|
| Cluster Analysis | 3 | 2010 | 2698 | 0.070 |
Why?
|
| Age Distribution | 3 | 2009 | 2893 | 0.070 |
Why?
|
| Rheology | 1 | 2007 | 348 | 0.070 |
Why?
|
| Vaccines, Conjugate | 1 | 2008 | 328 | 0.070 |
Why?
|
| Urologic Diseases | 1 | 2009 | 248 | 0.070 |
Why?
|
| Health Literacy | 1 | 2012 | 440 | 0.070 |
Why?
|
| Survivors | 1 | 2017 | 2375 | 0.070 |
Why?
|
| Cough | 1 | 2010 | 595 | 0.070 |
Why?
|
| Risk Reduction Behavior | 3 | 2021 | 1109 | 0.070 |
Why?
|
| Glottis | 1 | 2007 | 214 | 0.070 |
Why?
|
| Genetic Testing | 1 | 2019 | 3531 | 0.070 |
Why?
|
| Hypercholesterolemia | 1 | 2013 | 1155 | 0.070 |
Why?
|
| Phonation | 1 | 2007 | 220 | 0.070 |
Why?
|
| Crystallography, X-Ray | 3 | 2016 | 1982 | 0.070 |
Why?
|
| Pancreatic Neoplasms | 2 | 2019 | 5351 | 0.070 |
Why?
|
| Population Surveillance | 3 | 2008 | 2608 | 0.070 |
Why?
|
| Diffusion of Innovation | 1 | 2011 | 730 | 0.070 |
Why?
|
| Clinical Competence | 1 | 2001 | 4783 | 0.070 |
Why?
|
| Domestic Violence | 1 | 2007 | 181 | 0.060 |
Why?
|
| Grief | 2 | 1981 | 254 | 0.060 |
Why?
|
| Delivery of Health Care | 2 | 2021 | 5325 | 0.060 |
Why?
|
| Quality Assurance, Health Care | 1 | 2016 | 2176 | 0.060 |
Why?
|
| Pandemics | 2 | 2022 | 8624 | 0.060 |
Why?
|
| Continuity of Patient Care | 2 | 2011 | 1066 | 0.060 |
Why?
|
| Coronary Artery Disease | 2 | 2018 | 6659 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2024 | 36290 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2021 | 3426 | 0.060 |
Why?
|
| Sigmoidoscopy | 2 | 2021 | 150 | 0.060 |
Why?
|
| Gastroenterology | 2 | 1997 | 571 | 0.060 |
Why?
|
| Medication Adherence | 2 | 2019 | 2165 | 0.060 |
Why?
|
| Double-Blind Method | 5 | 2013 | 12427 | 0.060 |
Why?
|
| Expert Testimony | 1 | 2008 | 361 | 0.060 |
Why?
|
| Patient Care Management | 2 | 2005 | 303 | 0.060 |
Why?
|
| Regression Analysis | 6 | 2007 | 6360 | 0.060 |
Why?
|
| Office Visits | 2 | 2000 | 597 | 0.060 |
Why?
|
| Endosulfan | 1 | 2004 | 2 | 0.060 |
Why?
|
| Diagnosis, Differential | 8 | 2007 | 12965 | 0.060 |
Why?
|
| Infant, Newborn | 5 | 2023 | 26181 | 0.060 |
Why?
|
| Multivariate Analysis | 6 | 2010 | 12159 | 0.060 |
Why?
|
| Calcium | 1 | 2018 | 5725 | 0.060 |
Why?
|
| Patient Care | 1 | 2010 | 624 | 0.060 |
Why?
|
| Travel | 1 | 2010 | 785 | 0.060 |
Why?
|
| Nutrition Surveys | 2 | 2022 | 1725 | 0.060 |
Why?
|
| Fresh Water | 1 | 2004 | 82 | 0.060 |
Why?
|
| Hemorrhage | 3 | 2022 | 3600 | 0.060 |
Why?
|
| Blood Pressure | 2 | 2017 | 8525 | 0.060 |
Why?
|
| Fruit | 1 | 2009 | 1160 | 0.060 |
Why?
|
| Emigration and Immigration | 1 | 2007 | 395 | 0.060 |
Why?
|
| Child Welfare | 1 | 2008 | 516 | 0.060 |
Why?
|
| Radiation Injuries | 1 | 2011 | 1183 | 0.060 |
Why?
|
| Models, Anatomic | 1 | 2007 | 682 | 0.060 |
Why?
|
| Smallpox | 1 | 2004 | 43 | 0.060 |
Why?
|
| Stomatognathic Diseases | 1 | 2023 | 22 | 0.060 |
Why?
|
| Body Mass Index | 2 | 2017 | 12914 | 0.060 |
Why?
|
| Ethics, Medical | 1 | 2009 | 783 | 0.060 |
Why?
|
| Thyroid Neoplasms | 1 | 2017 | 2332 | 0.060 |
Why?
|
| Information Management | 1 | 2004 | 100 | 0.050 |
Why?
|
| Urinalysis | 1 | 2005 | 368 | 0.050 |
Why?
|
| Medical Informatics | 1 | 2010 | 732 | 0.050 |
Why?
|
| Carrier State | 1 | 2007 | 525 | 0.050 |
Why?
|
| Cost of Illness | 3 | 2019 | 1940 | 0.050 |
Why?
|
| Activities of Daily Living | 2 | 2022 | 2417 | 0.050 |
Why?
|
| Vocal Cords | 1 | 2007 | 523 | 0.050 |
Why?
|
| Sex Offenses | 1 | 2007 | 351 | 0.050 |
Why?
|
| Societies, Scientific | 1 | 2004 | 221 | 0.050 |
Why?
|
| Inpatients | 1 | 2015 | 2581 | 0.050 |
Why?
|
| Decision Support Systems, Clinical | 2 | 2015 | 1164 | 0.050 |
Why?
|
| Streptococcus pyogenes | 1 | 2005 | 294 | 0.050 |
Why?
|
| Obesity | 3 | 2021 | 12922 | 0.050 |
Why?
|
| Socioeconomic Factors | 5 | 2020 | 7806 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2006 | 829 | 0.050 |
Why?
|
| Heart Failure | 3 | 2015 | 11847 | 0.050 |
Why?
|
| Diphosphonates | 2 | 2018 | 638 | 0.050 |
Why?
|
| Rhabdomyolysis | 1 | 2004 | 155 | 0.050 |
Why?
|
| Autonomic Agents | 1 | 2002 | 7 | 0.050 |
Why?
|
| Information Services | 1 | 2004 | 235 | 0.050 |
Why?
|
| Withholding Treatment | 3 | 2016 | 613 | 0.050 |
Why?
|
| Epidemiologic Research Design | 1 | 2006 | 368 | 0.050 |
Why?
|
| Partial Thromboplastin Time | 1 | 2003 | 205 | 0.050 |
Why?
|
| Ultrasonography, Mammary | 1 | 2024 | 239 | 0.050 |
Why?
|
| Tuberculosis | 2 | 2023 | 2001 | 0.050 |
Why?
|
| Health Personnel | 1 | 2016 | 3310 | 0.050 |
Why?
|
| Child Health Services | 1 | 2007 | 644 | 0.050 |
Why?
|
| Preconception Care | 1 | 2023 | 139 | 0.050 |
Why?
|
| Life Tables | 2 | 2000 | 365 | 0.050 |
Why?
|
| Diagnosis, Oral | 1 | 2021 | 23 | 0.050 |
Why?
|
| Cholestasis | 1 | 1985 | 377 | 0.050 |
Why?
|
| Critical Illness | 1 | 2015 | 2709 | 0.050 |
Why?
|
| GABA Antagonists | 1 | 2002 | 120 | 0.050 |
Why?
|
| International Normalized Ratio | 1 | 2004 | 386 | 0.050 |
Why?
|
| Internationality | 1 | 2007 | 1004 | 0.050 |
Why?
|
| Weight Loss | 3 | 2018 | 2686 | 0.050 |
Why?
|
| Pilot Projects | 5 | 2022 | 8555 | 0.050 |
Why?
|
| Pamphlets | 1 | 2001 | 71 | 0.050 |
Why?
|
| GABA Agonists | 1 | 2002 | 105 | 0.050 |
Why?
|
| Pesticides | 1 | 2004 | 293 | 0.050 |
Why?
|
| Urethral Obstruction | 1 | 2001 | 56 | 0.050 |
Why?
|
| Goals | 2 | 2022 | 708 | 0.050 |
Why?
|
| Minnesota | 1 | 2002 | 340 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2021 | 20509 | 0.050 |
Why?
|
| Observation | 2 | 2017 | 312 | 0.050 |
Why?
|
| Lymphotoxin-alpha | 1 | 2001 | 94 | 0.050 |
Why?
|
| Diet | 2 | 2017 | 8010 | 0.050 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 2021 | 95 | 0.050 |
Why?
|
| Electrocoagulation | 1 | 2001 | 152 | 0.050 |
Why?
|
| Protein Engineering | 1 | 2005 | 541 | 0.050 |
Why?
|
| Terrorism | 1 | 2004 | 211 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 6068 | 0.050 |
Why?
|
| Estrogen Replacement Therapy | 2 | 2017 | 1206 | 0.050 |
Why?
|
| beta Carotene | 1 | 2022 | 524 | 0.050 |
Why?
|
| Hysterectomy | 2 | 2017 | 904 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2016 | 3765 | 0.050 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2019 | 2197 | 0.040 |
Why?
|
| Clinical Trials as Topic | 4 | 2006 | 8056 | 0.040 |
Why?
|
| Uric Acid | 2 | 2016 | 806 | 0.040 |
Why?
|
| Fetal Macrosomia | 1 | 2021 | 131 | 0.040 |
Why?
|
| Diagnostic Errors | 1 | 2008 | 1266 | 0.040 |
Why?
|
| Pregnancy Trimesters | 1 | 2021 | 197 | 0.040 |
Why?
|
| Radiosurgery | 1 | 2010 | 1343 | 0.040 |
Why?
|
| Laser Therapy | 2 | 2017 | 1089 | 0.040 |
Why?
|
| Hospitalization | 5 | 2015 | 10790 | 0.040 |
Why?
|
| Paternalism | 1 | 1999 | 47 | 0.040 |
Why?
|
| Men | 1 | 2020 | 64 | 0.040 |
Why?
|
| Hepatitis C Antibodies | 1 | 2020 | 145 | 0.040 |
Why?
|
| Acute Disease | 4 | 2005 | 7269 | 0.040 |
Why?
|
| Poisson Distribution | 2 | 1998 | 507 | 0.040 |
Why?
|
| Glucose Tolerance Test | 2 | 2021 | 1175 | 0.040 |
Why?
|
| Pyelonephritis | 1 | 2019 | 75 | 0.040 |
Why?
|
| Tobacco Use Cessation | 1 | 2021 | 93 | 0.040 |
Why?
|
| Personality Inventory | 1 | 2022 | 1018 | 0.040 |
Why?
|
| Herpes Simplex | 1 | 2023 | 478 | 0.040 |
Why?
|
| Ointments | 1 | 2019 | 58 | 0.040 |
Why?
|
| Drug Interactions | 1 | 2004 | 1428 | 0.040 |
Why?
|
| Videodisc Recording | 2 | 1995 | 14 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2019 | 17790 | 0.040 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2001 | 288 | 0.040 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2021 | 330 | 0.040 |
Why?
|
| Electronics | 1 | 2020 | 315 | 0.040 |
Why?
|
| Syphilis, Congenital | 1 | 2018 | 25 | 0.040 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2021 | 460 | 0.040 |
Why?
|
| Negotiating | 1 | 2020 | 148 | 0.040 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2021 | 732 | 0.040 |
Why?
|
| Rectal Neoplasms | 1 | 1987 | 1152 | 0.040 |
Why?
|
| Triamterene | 1 | 1997 | 3 | 0.040 |
Why?
|
| Chi-Square Distribution | 1 | 2004 | 3465 | 0.040 |
Why?
|
| Doxazosin | 1 | 1997 | 18 | 0.040 |
Why?
|
| Hospitals, Veterans | 1 | 2000 | 398 | 0.040 |
Why?
|
| Blindness | 1 | 2022 | 582 | 0.040 |
Why?
|
| Information Seeking Behavior | 1 | 2019 | 116 | 0.040 |
Why?
|
| Sex Factors | 3 | 2019 | 10547 | 0.040 |
Why?
|
| Urologic Surgical Procedures, Male | 1 | 2018 | 80 | 0.040 |
Why?
|
| Self-Examination | 1 | 2018 | 71 | 0.040 |
Why?
|
| Monitoring, Immunologic | 1 | 1998 | 98 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 2003 | 2234 | 0.040 |
Why?
|
| Environmental Monitoring | 1 | 2004 | 1441 | 0.040 |
Why?
|
| Mutation | 2 | 2019 | 29932 | 0.040 |
Why?
|
| Anisometropia | 1 | 2017 | 17 | 0.040 |
Why?
|
| Factor Analysis, Statistical | 1 | 2000 | 998 | 0.040 |
Why?
|
| Device Removal | 1 | 2003 | 636 | 0.040 |
Why?
|
| Multiple Sclerosis | 1 | 2013 | 3204 | 0.040 |
Why?
|
| Vitamin E | 1 | 2022 | 872 | 0.040 |
Why?
|
| Mandatory Reporting | 1 | 2018 | 124 | 0.040 |
Why?
|
| Hydrochlorothiazide | 1 | 1997 | 94 | 0.040 |
Why?
|
| Aging | 2 | 2001 | 8651 | 0.040 |
Why?
|
| Palpation | 1 | 1997 | 166 | 0.040 |
Why?
|
| Comorbidity | 3 | 2021 | 10551 | 0.040 |
Why?
|
| Mass Spectrometry | 2 | 2015 | 2192 | 0.040 |
Why?
|
| United States Agency for Healthcare Research and Quality | 2 | 1994 | 87 | 0.040 |
Why?
|
| Mental Health | 1 | 2012 | 3213 | 0.040 |
Why?
|
| Sunscreening Agents | 1 | 2018 | 139 | 0.040 |
Why?
|
| Cancer Vaccines | 1 | 2005 | 1046 | 0.040 |
Why?
|
| Braces | 1 | 2018 | 138 | 0.040 |
Why?
|
| Mortality | 1 | 2008 | 2916 | 0.040 |
Why?
|
| House Calls | 1 | 2018 | 160 | 0.040 |
Why?
|
| Administration, Topical | 1 | 2019 | 697 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2003 | 965 | 0.030 |
Why?
|
| Government Programs | 1 | 2019 | 280 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2012 | 3836 | 0.030 |
Why?
|
| Aortic Rupture | 1 | 2019 | 317 | 0.030 |
Why?
|
| Fallopian Tube Neoplasms | 1 | 2019 | 328 | 0.030 |
Why?
|
| Secondary Prevention | 2 | 2017 | 1548 | 0.030 |
Why?
|
| Menopause, Premature | 1 | 2017 | 125 | 0.030 |
Why?
|
| Pneumonia | 1 | 2008 | 2131 | 0.030 |
Why?
|
| Employment | 1 | 2003 | 1112 | 0.030 |
Why?
|
| Publication Bias | 1 | 2017 | 162 | 0.030 |
Why?
|
| Group Practice, Prepaid | 1 | 1996 | 15 | 0.030 |
Why?
|
| Mediastinal Diseases | 1 | 1997 | 91 | 0.030 |
Why?
|
| Styrenes | 1 | 2016 | 23 | 0.030 |
Why?
|
| Research | 3 | 1995 | 1974 | 0.030 |
Why?
|
| Organ Size | 1 | 2021 | 2254 | 0.030 |
Why?
|
| Ischemic Attack, Transient | 1 | 2022 | 901 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2005 | 3735 | 0.030 |
Why?
|
| Marijuana Abuse | 1 | 2020 | 411 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2017 | 665 | 0.030 |
Why?
|
| Skin Pigmentation | 1 | 2018 | 277 | 0.030 |
Why?
|
| Cognition | 2 | 2023 | 6957 | 0.030 |
Why?
|
| Self Report | 2 | 2019 | 3711 | 0.030 |
Why?
|
| Vermont | 1 | 1995 | 83 | 0.030 |
Why?
|
| Causality | 1 | 2002 | 1242 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2022 | 1791 | 0.030 |
Why?
|
| Clinical Protocols | 2 | 1992 | 1440 | 0.030 |
Why?
|
| Public Opinion | 2 | 2017 | 481 | 0.030 |
Why?
|
| Evidence-Based Practice | 1 | 2020 | 496 | 0.030 |
Why?
|
| Off-Label Use | 1 | 2017 | 184 | 0.030 |
Why?
|
| Colonic Neoplasms | 1 | 1987 | 2526 | 0.030 |
Why?
|
| Colorado | 1 | 1995 | 164 | 0.030 |
Why?
|
| Geriatrics | 1 | 2000 | 387 | 0.030 |
Why?
|
| Models, Molecular | 2 | 2016 | 5434 | 0.030 |
Why?
|
| Colchicine | 1 | 2016 | 261 | 0.030 |
Why?
|
| Sulfonylurea Compounds | 1 | 2017 | 221 | 0.030 |
Why?
|
| Anti-Obesity Agents | 1 | 2018 | 229 | 0.030 |
Why?
|
| Teriparatide | 1 | 2017 | 227 | 0.030 |
Why?
|
| Reoperation | 4 | 2000 | 4291 | 0.030 |
Why?
|
| Gout Suppressants | 1 | 2016 | 177 | 0.030 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2016 | 618 | 0.030 |
Why?
|
| Glioma | 1 | 2009 | 3420 | 0.030 |
Why?
|
| Feasibility Studies | 2 | 2017 | 5201 | 0.030 |
Why?
|
| Haplotypes | 1 | 2001 | 2764 | 0.030 |
Why?
|
| Models, Biological | 2 | 2008 | 9467 | 0.030 |
Why?
|
| Medicare Part A | 1 | 1994 | 40 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 13630 | 0.030 |
Why?
|
| Cervix Uteri | 1 | 2018 | 582 | 0.030 |
Why?
|
| Hospitals, General | 2 | 2016 | 795 | 0.030 |
Why?
|
| Fear | 1 | 2023 | 1462 | 0.030 |
Why?
|
| Synovial Fluid | 1 | 2016 | 395 | 0.030 |
Why?
|
| Diet, Gluten-Free | 1 | 2017 | 280 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2017 | 6544 | 0.030 |
Why?
|
| Calcium, Dietary | 1 | 2017 | 531 | 0.030 |
Why?
|
| Oxidoreductases | 1 | 1996 | 412 | 0.030 |
Why?
|
| Emigrants and Immigrants | 1 | 2020 | 539 | 0.030 |
Why?
|
| Biomedical Technology | 1 | 2016 | 211 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2021 | 1431 | 0.030 |
Why?
|
| Sepsis | 1 | 2008 | 2592 | 0.030 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2017 | 393 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 2016 | 1628 | 0.030 |
Why?
|
| Mind-Body Therapies | 1 | 2017 | 265 | 0.030 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2017 | 357 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2005 | 2725 | 0.030 |
Why?
|
| Self-Assessment | 1 | 1996 | 393 | 0.030 |
Why?
|
| Australia | 1 | 2017 | 1289 | 0.030 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2014 | 267 | 0.030 |
Why?
|
| Individuality | 1 | 1995 | 300 | 0.030 |
Why?
|
| North America | 1 | 1997 | 1284 | 0.030 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2019 | 2569 | 0.030 |
Why?
|
| Strabismus | 1 | 2017 | 317 | 0.030 |
Why?
|
| Nomograms | 1 | 2015 | 238 | 0.030 |
Why?
|
| Peritoneal Neoplasms | 1 | 2019 | 707 | 0.030 |
Why?
|
| Social Values | 1 | 1994 | 225 | 0.030 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2016 | 489 | 0.030 |
Why?
|
| Policy Making | 1 | 2016 | 538 | 0.030 |
Why?
|
| Resuscitation Orders | 1 | 2015 | 270 | 0.030 |
Why?
|
| Visual Acuity | 1 | 2022 | 2643 | 0.030 |
Why?
|
| Pancreas | 1 | 2019 | 1677 | 0.030 |
Why?
|
| Likelihood Functions | 4 | 1997 | 987 | 0.030 |
Why?
|
| Environmental Pollutants | 1 | 2002 | 1266 | 0.030 |
Why?
|
| Acupuncture Therapy | 1 | 2017 | 480 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2018 | 1736 | 0.020 |
Why?
|
| HIV | 1 | 2019 | 1579 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2017 | 2852 | 0.020 |
Why?
|
| Complementary Therapies | 1 | 2016 | 486 | 0.020 |
Why?
|
| Hydrodynamics | 1 | 2013 | 167 | 0.020 |
Why?
|
| Drug Combinations | 1 | 1997 | 2025 | 0.020 |
Why?
|
| Diabetic Angiopathies | 1 | 2017 | 822 | 0.020 |
Why?
|
| Maine | 2 | 1988 | 145 | 0.020 |
Why?
|
| Personal Autonomy | 1 | 1994 | 302 | 0.020 |
Why?
|
| Precancerous Conditions | 1 | 2018 | 977 | 0.020 |
Why?
|
| Medical Records Systems, Computerized | 2 | 2008 | 1191 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2011 | 5870 | 0.020 |
Why?
|
| Hospital-Physician Joint Ventures | 1 | 2010 | 30 | 0.020 |
Why?
|
| Diastole | 1 | 2013 | 788 | 0.020 |
Why?
|
| Myocardial Infarction | 2 | 2022 | 11891 | 0.020 |
Why?
|
| Aviation | 1 | 2010 | 49 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2007 | 6465 | 0.020 |
Why?
|
| Exercise Test | 1 | 2018 | 2128 | 0.020 |
Why?
|
| Glucose | 1 | 2022 | 4351 | 0.020 |
Why?
|
| Cryosurgery | 1 | 1995 | 475 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2017 | 1435 | 0.020 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1997 | 1131 | 0.020 |
Why?
|
| Overweight | 1 | 2021 | 2421 | 0.020 |
Why?
|
| Patient Selection | 1 | 2022 | 4283 | 0.020 |
Why?
|
| Analgesics | 1 | 2017 | 1065 | 0.020 |
Why?
|
| Hepatitis C | 1 | 2020 | 1579 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2001 | 4357 | 0.020 |
Why?
|
| Prenatal Care | 1 | 2017 | 1129 | 0.020 |
Why?
|
| Life Support Care | 1 | 1991 | 222 | 0.020 |
Why?
|
| Morbidity | 1 | 1995 | 1765 | 0.020 |
Why?
|
| Medicine | 1 | 1997 | 943 | 0.020 |
Why?
|
| Canada | 1 | 1994 | 2128 | 0.020 |
Why?
|
| Spirituality | 1 | 2014 | 428 | 0.020 |
Why?
|
| Community Networks | 1 | 2010 | 201 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2022 | 6218 | 0.020 |
Why?
|
| Ecosystem | 1 | 2013 | 485 | 0.020 |
Why?
|
| Outpatients | 2 | 1994 | 1607 | 0.020 |
Why?
|
| Placebos | 1 | 2013 | 1668 | 0.020 |
Why?
|
| Crohn Disease | 1 | 2001 | 2275 | 0.020 |
Why?
|
| Comprehension | 1 | 1994 | 618 | 0.020 |
Why?
|
| Fibrinolytic Agents | 1 | 2018 | 2167 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2009 | 8986 | 0.020 |
Why?
|
| Registries | 2 | 2008 | 8469 | 0.020 |
Why?
|
| Pain | 1 | 2003 | 5066 | 0.020 |
Why?
|
| Emergency Medical Services | 2 | 2013 | 1925 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2016 | 1869 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2001 | 3323 | 0.020 |
Why?
|
| Barium Sulfate | 1 | 1987 | 180 | 0.020 |
Why?
|
| Neoplasm Metastasis | 2 | 1995 | 4902 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2020 | 7021 | 0.020 |
Why?
|
| Health Resources | 1 | 2013 | 935 | 0.020 |
Why?
|
| Urban Health | 1 | 2009 | 533 | 0.020 |
Why?
|
| Length of Stay | 3 | 2009 | 6479 | 0.020 |
Why?
|
| Movement | 1 | 2013 | 1474 | 0.020 |
Why?
|
| Cholestasis, Extrahepatic | 1 | 1985 | 51 | 0.020 |
Why?
|
| Linear Models | 1 | 2015 | 5877 | 0.020 |
Why?
|
| Heart Rate | 1 | 2017 | 4179 | 0.020 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 1985 | 75 | 0.020 |
Why?
|
| Medically Uninsured | 1 | 2010 | 843 | 0.020 |
Why?
|
| Perception | 1 | 2011 | 1195 | 0.010 |
Why?
|
| Child Abuse, Sexual | 1 | 2007 | 392 | 0.010 |
Why?
|
| Health Care Reform | 1 | 1993 | 1245 | 0.010 |
Why?
|
| Pressure | 1 | 2007 | 1156 | 0.010 |
Why?
|
| Catheter Ablation | 1 | 1997 | 2758 | 0.010 |
Why?
|
| Recurrence | 1 | 2016 | 8482 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2001 | 9185 | 0.010 |
Why?
|
| Motion | 1 | 2007 | 779 | 0.010 |
Why?
|
| Video Recording | 1 | 2009 | 955 | 0.010 |
Why?
|
| Disease-Free Survival | 2 | 2006 | 6828 | 0.010 |
Why?
|
| Physician's Role | 1 | 1991 | 918 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2009 | 2295 | 0.010 |
Why?
|
| Perindopril | 1 | 2003 | 13 | 0.010 |
Why?
|
| Self Disclosure | 1 | 2004 | 249 | 0.010 |
Why?
|
| Self Care | 1 | 1989 | 793 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2005 | 736 | 0.010 |
Why?
|
| Chickenpox | 1 | 2004 | 97 | 0.010 |
Why?
|
| Animals | 3 | 2005 | 167963 | 0.010 |
Why?
|
| Adaptation, Psychological | 1 | 2014 | 2628 | 0.010 |
Why?
|
| Program Development | 1 | 2009 | 1297 | 0.010 |
Why?
|
| Furosemide | 1 | 2003 | 170 | 0.010 |
Why?
|
| Needs Assessment | 1 | 2008 | 1139 | 0.010 |
Why?
|
| Lung | 1 | 2021 | 9994 | 0.010 |
Why?
|
| Random Allocation | 2 | 1997 | 2394 | 0.010 |
Why?
|
| Digoxin | 1 | 2003 | 247 | 0.010 |
Why?
|
| Information Dissemination | 1 | 2010 | 1131 | 0.010 |
Why?
|
| User-Computer Interface | 1 | 2008 | 1403 | 0.010 |
Why?
|
| Rectum | 2 | 1997 | 895 | 0.010 |
Why?
|
| Cardiology | 1 | 2013 | 1723 | 0.010 |
Why?
|
| Social Class | 1 | 2010 | 2005 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2005 | 1636 | 0.010 |
Why?
|
| Florida | 1 | 2002 | 430 | 0.010 |
Why?
|
| Language | 1 | 2010 | 1533 | 0.010 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2003 | 389 | 0.010 |
Why?
|
| Psychotherapy, Brief | 1 | 1981 | 118 | 0.010 |
Why?
|
| Syndrome | 1 | 2007 | 3280 | 0.010 |
Why?
|
| Echocardiography | 1 | 2013 | 4981 | 0.010 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2007 | 1489 | 0.010 |
Why?
|
| Diuretics | 1 | 2003 | 613 | 0.010 |
Why?
|
| Physicians, Women | 1 | 2006 | 495 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2010 | 2283 | 0.010 |
Why?
|
| Radiotherapy, Conformal | 1 | 2002 | 549 | 0.010 |
Why?
|
| Lumbar Vertebrae | 1 | 2008 | 1868 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2009 | 2985 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 2001 | 786 | 0.010 |
Why?
|
| Medical Staff, Hospital | 1 | 2003 | 600 | 0.010 |
Why?
|
| History, 21st Century | 1 | 2004 | 1575 | 0.010 |
Why?
|
| Developing Countries | 1 | 2010 | 2868 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 3800 | 0.010 |
Why?
|
| Bronchogenic Cyst | 1 | 1997 | 28 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2012 | 8035 | 0.010 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2003 | 1523 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2005 | 2488 | 0.010 |
Why?
|
| History, 20th Century | 1 | 2004 | 2773 | 0.010 |
Why?
|
| Prepaid Health Plans | 1 | 1995 | 9 | 0.010 |
Why?
|
| Palliative Care | 1 | 2009 | 3607 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2005 | 5496 | 0.010 |
Why?
|
| Fecal Incontinence | 1 | 1996 | 241 | 0.010 |
Why?
|
| Repression, Psychology | 1 | 1973 | 46 | 0.010 |
Why?
|
| Surgical Procedures, Operative | 2 | 1995 | 1913 | 0.010 |
Why?
|
| Mental Competency | 1 | 1994 | 175 | 0.010 |
Why?
|
| Decision Trees | 1 | 1994 | 506 | 0.010 |
Why?
|
| Hematoma | 1 | 1997 | 769 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2011 | 6796 | 0.010 |
Why?
|
| Reference Standards | 1 | 1995 | 1004 | 0.010 |
Why?
|
| Constipation | 1 | 1996 | 561 | 0.010 |
Why?
|
| Hospital Bed Capacity, 500 and over | 1 | 1991 | 114 | 0.010 |
Why?
|
| Manitoba | 1 | 1990 | 24 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2001 | 4291 | 0.010 |
Why?
|
| Object Attachment | 1 | 1973 | 324 | 0.010 |
Why?
|
| Coma | 1 | 1994 | 487 | 0.010 |
Why?
|
| Resuscitation | 1 | 1994 | 661 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2005 | 18957 | 0.010 |
Why?
|
| Pregnancy Tests | 1 | 1989 | 33 | 0.010 |
Why?
|
| Diagnosis-Related Groups | 1 | 1990 | 450 | 0.000 |
Why?
|
| Pediatrics | 1 | 2004 | 3586 | 0.000 |
Why?
|
| Catheterization | 1 | 1994 | 1432 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 2005 | 22023 | 0.000 |
Why?
|
| Health Services Needs and Demand | 1 | 1993 | 1399 | 0.000 |
Why?
|
| Medical Records | 1 | 1990 | 1407 | 0.000 |
Why?
|
| Respiration, Artificial | 1 | 1994 | 2622 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2005 | 23376 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1996 | 11481 | 0.000 |
Why?
|
| Mice | 1 | 2005 | 81208 | 0.000 |
Why?
|
| Insurance, Health | 1 | 1988 | 2501 | 0.000 |
Why?
|